Intralesional steroids for alopecia areata

International Journal of Trichology

Volumn 2, Issue 1, 2010, Pages 63-65

  Kumaresan, M ^a  

^a PSG HOSPITALS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864874902     PISSN: 09747753     EISSN: 09749241     Source Type: Journal    
DOI: 10.4103/0974-7753.66920     Document Type: Article

References (17)

1. Kalkoff K W, Macher E. Growing of hair in Alopecia Areata and maligna after intracutaneous hydrocortisone injection. Hautarzt 1958;9:441-51.
2. Mandani S, Shapiro J. Alopecia Areata update. J Am Acad Dermatol 2000;42:549-66.
3. Shapiro J, Price VH. Hair regrowth: Therapeutic agents. Dermatol Clin 1998;16:341-56.
4. Shapiro J. Alopecia Areata: Update on therapy. Dermatol Clin 1993;11:35-46.
5. Chang KH, Rojhirunsakool S, Goldberg LJ. Treatment of severe Alopecia Areata with intralesional steroid injections. J Drugs Dermatol 2009;8:909-12.
6. Alopecia Areata: A workshop: Bethesda, Maryland, October 25-26, 1990. J Invest Dermatol 1991;96:67S-100S.
7. Abell E, Munro DD. ntralesional treatment of Alopecia Areata with triamcinolone acetonide by jet injector. Br J Dermatol 1973;88:55-9.
8. Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for Alopecia Areata. Cochrane Database Syst Rev 2008;2:CD004413.
9. Garg S, Messenger AG. Alopecia Areata: Evidence-based treatments. Semin Cutan Med Surg 2009;28:15-8.
10. Porter D, Burton JL. A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in Alopecia Areata. Br J Dermatol 1971;85:272-3.
11. Kubeyinje EP. Intralesional triamcinolone acetonide in Alopecia Areata amongst 62 Saudi Arabs. East Afr Med J 1994;71:674-5.
12. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia Areata update: Part II: Treatment. J Am Acad Dermatol 2010;62:191-202.
13. Sawaya ME, Hordinsky MK. Glucocorticoid regulation of hair growth in Alopecia Areata. J Invest Dermatol 1995;104:30S.
14. Sohn KC, Jang S, Choi DK, Lee YS, Yoon TJ, Jeon EK, et al. Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cells. Biochem Biophys Res Commun 2007;356:810-5.
15. Gomez EC, Berman B, Miller DL. Ultrasonic assessment of cutaneous atrophy caused by intradermal corticosteroids. J Dermatol Surg Oncol 1982;8:1071-4.
16. Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol 2000;11:478-83.
17. Downs AM, Lear JT, Kennedy CT. Anaphylaxis to intradermal triamcinolone acetonide. Arch Dermatol 1998;134:1163-4.